Please check the following:
- {{error.value}}
FREE membership
FREE membership
Join InvestSMART today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Start your free 15 day trial now' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
OR
Sign up with
Login with
By continuing, you agree to our
Log in
Your account has been locked.
Please contact our {{ isPMAUser ? 'Portfolio Services' : 'Customer Service' }} Team:
- Call 1300 880 160
Looks you are already a member. Please enter your password to proceed
OR
Sign up with
Login with
By continuing, you agree to our
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Your account has been locked.
Please contact our {{ isPMAUser ? 'Portfolio Services' : 'Customer Service' }} Team:
- Call 1300 880 160
OR
Sign up with
Login with
By continuing, you agree to our
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Check your inbox
- Verify your email address by clicking on the link we sent to {{user.Email}}
- You now have free access, we look forward to helping you on your financial journey.
EVE Health Group Limited (ASX:EVE)
ALERT: Price-sensitive ASX Announcement for EVE
Current share price for EVE : $0.016 -0.01 (-38.46%)+
Announcement
Release
31 Oct 2025 11:22AM
Price at Release
$0.026
Full Release
Summary
EVE Health Group Limited reported significant progress in its September 2025 Quarterly Update, focusing on products Dyspro™ and Libbo™. The company completed the first prescriptions of Dyspro™, a cannabinoid-based gummy for women's health, and initiated the commercial order for Libbo™, an oral dissolving film for erectile dysfunction. EVE also launched Reclaim My Cycle, an educational platform for women's health, and established a Scientific Advisory Board. Financially, EVE raised $1.1 million in October 2025 to support product rollouts. Despite cash flows showing a decrease, strategic steps have been taken to secure the company's operational future.
Key Points
- $1.1 million placement in October to support Dyspro™ and Libbo™ rollout.
- First patient prescriptions of Dyspro™ completed.
- Launch of Reclaim My Cycle online women’s health hub.
- First purchase order for Libbo™ placed.
- Scientific Advisory Board established with Dr Fiona Cousins.
- Regulatory milestones for Dyspro™ and Libbo™ met.
- Company raised $1.1 million post-quarter for product rollout.
- Cash at bank was $0.4 million at end of September 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
